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Abstract
Introduction: Oncocytic carcinoma is a rare proliferation of cytomorphologically malignant oncocytes mainly
found in glandular tissue, accounting for 0.5% of all epithelial salivary gland malignancies and 0.18% of all epithelial
salivary gland tumors.
Case presentation: We report a case of oncocytic carcinoma arising in the parotid gland of a 65-year-old
Caucasian man. Our patient initially underwent left superficial parotidectomy, including the removal of the mass. A
close follow-up was made, and four years after first surgery cervical lymph node metastases were confirmed.
Therefore, a complete parotidectomy and radical neck dissections were performed. There were no complications
and no sign of recurrence after six months of follow-up.
Conclusion: Oncocytic carcinoma is an extremely rare malignancy in the salivary glands. Prophylactic neck
dissection may be indicated for tumors larger than 2 cm in diameter (our patient’s tumor was 2.5 cm at its
greatest diameter). The clinical course of our patient, with the appearance of cervical lymph node metastases after
four years of follow-up, supports this approach. Further investigation of the prognosis and correct treatment of
patients with oncocytic carcinoma are required as more cases are reported.
Introduction
Oncocytic carcinoma (OC) is an unusual proliferation of
cytomorphologically malignant oncocytes and adenocar-
cinomatous architecture phenotypes mainly found in
glandular tissue [1]. The terms oncocytic carcinoma,
oncocytic adenocarcinoma, malignant oncocytoma and
malignant oxyphilic adenoma are synonymous. Its
malignant nature is distinguished from oncocytoma by
abnormal morphological features and infiltrative growth
[2]. Necrosis, peri-neural spread, pleomorphism, intra-
vascular invasion, and distant metastasis to the cervical
lymph nodes, kidneys, lungs, and mediastinum are the
main features of this high-grade malignant tumor [1].
This tumor represents 5% of all oncocytic salivary
gland neoplasms and less than 1% of all salivary gland
tumors [3]. OC may occur in many sites in addition to
the salivary glands, including the nasal and thoracic cav-
ities, ovary, kidney, thyroid gland, breast and
parathyroid. The majority of OC cases have occurred in
the parotid glands, but tumors that involved the sub-
mandibular gland and minor glands of the palate have
also been described [4].
In this case report we describe a case of OC that arose
in our patient’s parotid gland and presented regional
lymph node metastases four years after first surgery.
Case presentation
A 65-year-old Caucasian man presented with a one-year
history of a painless mass in the left parotid gland. Phy-
sical examination revealed an elastic, movable and non-
tender mass. There was no facial palsy or regional lym-
phadenopathy. A computed tomography (CT) scan
revealed a 20×25 mm mass in the anterior portion of
the gland, near the parotid duct, resembling a mixed
tumor (Figure 1A). The cervical and peri-aortic lymph
nodes were not enlarged. No calcification or cystic com-
ponent was seen within the tumor. Fine-needle aspira-
tion cytology (FNAC) results showed no signs of
malignancy.
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parotidectomy, including the removal of the mass.
Because of clear infiltration of the tumor, the buccal
branch of the facial nerve was resected. Macroscopically,
the tumor was a well-circumscribed, firm, grey-brown,
ovoid nodule measuring 2.5 cm in diameter. Microscopic
examination revealed that the neoplasm had replaced a
wide area of the parotid gland and peri-neural invasion
was found (Figure 1B). The neoplastic elements were
large, round or polyhedral cells and were arranged in
solid sheets, islands and cords. The cytoplasm was abun-
dant, eosinophilic and finely granular, characteristics
indicative of oncocytes (Figure 1C). A diagnosis of OC
was based on these histopathological findings and in par-
ticular on the invasive growth pattern.
We preferred a close follow-up to an elective neck dis-
section, and reserved the neck dissection for a recur-
rence, as there was no lymph node involvement either
clinically or radiologically. Our patient was followed up
accordingly, and four years after surgery started
complaining of swelling and pain in the left cervical
area. Physical examination revealed an elastically hard
and poorly defined left cervical mass. There were no
signs of local recurrence. FNAC showed oncocytes and
atypical cells. A CT scan demonstrated several enlarged
lymph nodes in the left parotid gland and on the left
side of the neck (Figure 2A). Therefore, a complete par-
otidectomy and radical neck dissection were performed.
A microscopic examination of tissue samples confirmed
that three lymph nodes were positive for metastases, as
they had the same histopathological features as the pri-
mary tumor (Figure 2B). Post-operatively there were no
complications and no sign of recurrence after six
months follow-up.
Discussion
OC is an extremely rare malignancy in salivary glands,
accounting for just 0.5% of all epithelial salivary gland
malignancies and 0.18% of all epithelial salivary gland
tumors [5]. Criteria for the diagnosis of malignancy in
Figure 1 A) Computed tomography image revealing a well demarcated mass in the anterior portion of the left parotid gland
resembling a mixed tumor (red arrow). B) Histopathological image showing peri-neural invasion by the tumor and cohesive clusters of
neoplastic cells (hematoxylin and eosin stain, original magnification 250×). C) High magnification image demonstrating oncocytic cells with
abundant and finely granular cytoplasm and moderately pleomorphic nuclei located centrally or peripherally (hematoxylin and eosin stain,
original magnification 400×).
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metastasis; (2) distant metastasis; (3) peri-neural, vascu-
lar or lymphatic invasion; (4) frequent mitoses and cel-
lular pleomorphism with extensive invasion and
destruction of adjacent structures [6]. This tumor is pre-
dominantly composed of round or polyhedral cells
arranged in small clusters and occasional solid sheets.
Cells have abundant eosinophilic cytoplasm, a result of
excessive numbers of mitochondria [1]. Although not
commonly used, it has been reported that anti-mito-
chondrial antibody is highly specific and sensitive to
confirm the oncocytic nature of the granular cytoplasm
[7]. FNAC is less sensitive for oncocytic neoplasms, per-
haps due to the rarity of these tumors and diagnostic
pitfalls previously associated with FNAC (for example,
sampling errors and overinterpretation of paucicellular
specimens) [2].
Approximately one-third of patients with oncocytic
carcinoma of the parotid develop a painful mass or
experience facial paralysis. The skin overlying the gland
is occasionally discolored or wrinkled [1]. In our case,
there was no facial paralysis or discoloration of the
overlying skin. The average age of patients has been
estimated to be about 60 years, with a male predomi-
nance [1,8].
As with other high-grade salivary gland neoplasms,
aggressive surgical intervention is indicated. Therapy for
OCs consists of surgical intervention, and total paroti-
dectomy with preservation of the facial nerve whenever
possible. The efficacy of radiotherapy is unclear. Radia-
tion does not appear to favorably alter the biological
behavior of this tumor. In the case reported, intra-
operative frozen sections of the tumor would have been
indicated for pathological diagnosis and would have
altered the surgical decision. FNAC alone did not deter-
mine a correct diagnosis and the first surgical manage-
ment was inadequate.
A number of studies have reported multiple recur-
rences of this tumor and regional or distant metastases
[2,6,8-10]. The cervical lymph nodes may be affected as
with other malignant tumors of the parotid gland, but
prophylactic neck dissection must be considered indivi-
dually in the absence of consensus in the literature.
Nakada et al. published a review of 28 cases of oncocy-
tic carcinoma of the parotid gland [8]. They concluded
that distant metastasis appeared to be the most impor-
tant prognostic feature of oncocytic carcinoma; local
lymph node metastasis was not necessarily a critical fac-
tor in the overall prognosis. Distant metastasis sites
include the lung, liver, kidney, mediastinum, thyroid
gland and bone.
Prophylactic neck dissection may be indicated for
tumors larger than 2 cm in diameter [10] (our patient’s
tumor was 2.5 cm at its greatest diameter). This likely
indicates a worse prognosis. The clinical course of our
case, with the appearance of cervical lymph node metas-
t a s e sa f t e rf o u ry e a r so ff o l l o w - u p ,s u p p o r t st h e
approach of Goode and Corio [10].
The prognosis of oncocytic carcinomas is not well
known because of their low incidence. Patients with
malignant oncocytoma appear to have good short-term
survival, but poor long-term survival [11]. The average
survival period has been estimated at 3.8 years with
metastasizing tumors [12]. Further investigation of the
Figure 2 A) Computed tomography image four years after first surgery revealing a cervical lymph node enlargement (red arrow).B )
Histopathological study of cervical specimen showing metastatic tumor infiltration by oncocytic cells (hematoxylin and eosin stain, original
magnification 400×).
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required as more cases are reported.
Conclusion
OC is an extremely rare malignancy in salivary glands,
and standard treatment and prognosis is unclear. Clini-
cians should perform a careful follow-up, as distant
metastasis appeared to be the most important prognos-
tic feature.
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